1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing Demand for Biopharmaceuticals & Government Support for the Industry
5.1.1.2. Increased Benefits over Batch Processing & Uptake of Single Use Technology
5.1.1.3. Advent of Industry 4.0 & Trend Towards Automation & Digitization
5.1.2. Restraints
5.1.2.1. Strict Regulations for Continuous Bioprocessing Coupled with High Equipment Cost
5.1.3. Opportunities
5.1.3.1. Adoption of Perfusion Associated with Single-Use Equipment
5.1.3.2. Development of a Continuous Bioprocessing Approach to Stromal Cell Manufacturing
5.1.4. Challenges
5.1.4.1. Issues with Operational Difficulties and Process Changes
5.2. Cumulative Impact of COVID-19

6. Continuous Bioprocessing Market, by Product
6.1. Introduction
6.2. Bioreactors
6.3. Cell Culture Media & Reagent
6.4. Centrifuges
6.5. Chromatography System & Consumable
6.6. Filtration Systems and Consumables
6.7. Incubators & Shakers
6.8. Mixing Systems

7. Continuous Bioprocessing Market, by End-User
7.1. Introduction
7.2. Academic & Research Institutes
7.3. Contract Development & Manufacturing Organizations
7.4. Pharmaceutical & Biotechnology Companies

8. Continuous Bioprocessing Market, by Application
8.1. Introduction
8.2. Commercial
8.2.1. Cell & Gene Therapy Production
8.2.2. Monoclonal Antibodies Production
8.2.3. Plasma Fractionation
8.2.4. Recombinant Protein Production
8.2.5. Vaccine Manufacturing
8.3. Research & Development

9. Americas Continuous Bioprocessing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Continuous Bioprocessing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand

11. Europe, Middle East & Africa Continuous Bioprocessing Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. 3M Company
13.2. Applikon Biotechnology B.V.
13.3. Bio-Rad Laboratories, Inc.
13.4. Bionet
13.5. Colder Products Company
13.6. Danaher Corporation
13.7. Eppendorf AG
13.8. Fujifilm Holdings Corporation
13.9. GE Healthcare
13.10. Lonza Group
13.11. Merck KGaA
13.12. Repligen Corporation
13.13. Sartorius AG
13.14. Thermo Fisher Scientific Inc.
13.15. Watson-Marlow Fluid Technology Group
13.16. WuXi Biologics

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL CONTINUOUS BIOPROCESSING MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL CONTINUOUS BIOPROCESSING MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 4. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2026
FIGURE 6. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTORS, 2018-2026 (USD MILLION)
FIGURE 7. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTORS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 8. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL CULTURE MEDIA & REAGENT, 2018-2026 (USD MILLION)
FIGURE 9. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL CULTURE MEDIA & REAGENT, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 10. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CENTRIFUGES, 2018-2026 (USD MILLION)
FIGURE 11. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CENTRIFUGES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 12. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CHROMATOGRAPHY SYSTEM & CONSUMABLE, 2018-2026 (USD MILLION)
FIGURE 13. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CHROMATOGRAPHY SYSTEM & CONSUMABLE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 14. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY FILTRATION SYSTEMS AND CONSUMABLES, 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY FILTRATION SYSTEMS AND CONSUMABLES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 16. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY INCUBATORS & SHAKERS, 2018-2026 (USD MILLION)
FIGURE 17. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY INCUBATORS & SHAKERS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 18. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MIXING SYSTEMS, 2018-2026 (USD MILLION)
FIGURE 19. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MIXING SYSTEMS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 20. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
FIGURE 21. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2020 VS 2026 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2026
FIGURE 23. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2026 (USD MILLION)
FIGURE 24. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 25. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, 2018-2026 (USD MILLION)
FIGURE 26. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 27. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2026 (USD MILLION)
FIGURE 28. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 29. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 30. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2026
FIGURE 32. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2026 (USD MILLION)
FIGURE 33. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 34. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL & GENE THERAPY PRODUCTION, 2018-2026 (USD MILLION)
FIGURE 35. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL & GENE THERAPY PRODUCTION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 36. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MONOCLONAL ANTIBODIES PRODUCTION, 2018-2026 (USD MILLION)
FIGURE 37. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MONOCLONAL ANTIBODIES PRODUCTION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 38. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PLASMA FRACTIONATION, 2018-2026 (USD MILLION)
FIGURE 39. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PLASMA FRACTIONATION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 40. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEIN PRODUCTION, 2018-2026 (USD MILLION)
FIGURE 41. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEIN PRODUCTION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 42. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINE MANUFACTURING, 2018-2026 (USD MILLION)
FIGURE 43. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINE MANUFACTURING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 44. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2026 (USD MILLION)
FIGURE 45. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 46. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. AUSTRALIA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. CHINA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. INDIA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. INDONESIA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. JAPAN CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. MALAYSIA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. PHILIPPINES CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. SINGAPORE CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. SOUTH KOREA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 62. TAIWAN CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 63. THAILAND CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 64. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 65. FRANCE CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 66. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 67. ITALY CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 68. NETHERLANDS CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 69. QATAR CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 70. RUSSIA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 71. SAUDI ARABIA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 72. SOUTH AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 73. SPAIN CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 74. UNITED ARAB EMIRATES CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 75. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 76. GLOBAL CONTINUOUS BIOPROCESSING MARKET: FPNV POSITIONING MATRIX
FIGURE 77. GLOBAL CONTINUOUS BIOPROCESSING MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 78. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CONTINUOUS BIOPROCESSING MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL CONTINUOUS BIOPROCESSING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL CULTURE MEDIA & REAGENT, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CHROMATOGRAPHY SYSTEM & CONSUMABLE, BY REGION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY FILTRATION SYSTEMS AND CONSUMABLES, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY INCUBATORS & SHAKERS, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MIXING SYSTEMS, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL & GENE THERAPY PRODUCTION, BY REGION, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MONOCLONAL ANTIBODIES PRODUCTION, BY REGION, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PLASMA FRACTIONATION, BY REGION, 2018-2026 (USD MILLION)
TABLE 20. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEIN PRODUCTION, BY REGION, 2018-2026 (USD MILLION)
TABLE 21. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINE MANUFACTURING, BY REGION, 2018-2026 (USD MILLION)
TABLE 22. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2026 (USD MILLION)
TABLE 23. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. AUSTRALIA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. CHINA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. INDIA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. INDONESIA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. JAPAN CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. MALAYSIA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. PHILIPPINES CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. SINGAPORE CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. SOUTH KOREA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. TAIWAN CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. THAILAND CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. FRANCE CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 44. ITALY CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 45. NETHERLANDS CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 46. QATAR CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 47. RUSSIA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 48. SAUDI ARABIA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 49. SOUTH AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 50. SPAIN CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 51. UNITED ARAB EMIRATES CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 52. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 53. GLOBAL CONTINUOUS BIOPROCESSING MARKET: SCORES
TABLE 54. GLOBAL CONTINUOUS BIOPROCESSING MARKET: BUSINESS STRATEGY
TABLE 55. GLOBAL CONTINUOUS BIOPROCESSING MARKET: PRODUCT SATISFACTION
TABLE 56. GLOBAL CONTINUOUS BIOPROCESSING MARKET: RANKING
TABLE 57. GLOBAL CONTINUOUS BIOPROCESSING MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 58. GLOBAL CONTINUOUS BIOPROCESSING MARKET: MERGER & ACQUISITION
TABLE 59. GLOBAL CONTINUOUS BIOPROCESSING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 60. GLOBAL CONTINUOUS BIOPROCESSING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 61. GLOBAL CONTINUOUS BIOPROCESSING MARKET: INVESTMENT & FUNDING
TABLE 62. GLOBAL CONTINUOUS BIOPROCESSING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 63. GLOBAL CONTINUOUS BIOPROCESSING MARKET: LICENSE & PRICING

Companies Mentioned

3M Company
Applikon Biotechnology B.V.
Bio-Rad Laboratories, Inc.
Bionet
Colder Products Company
Danaher Corporation
Eppendorf AG
Fujifilm Holdings Corporation
GE Healthcare
Lonza Group
Merck KGaA
Repligen Corporation
Sartorius AG
Thermo Fisher Scientific Inc.
Watson-Marlow Fluid Technology Group
WuXi Biologics